Company
United StatesPublic company, NASDAQ: ABEOAbeona Therapeutics, Inc. (NASDAQ: ABEO), Cleveland, OH – FDA Inspections
Inspection records and compliance data for Abeona Therapeutics, Inc. in Cleveland, Ohio. 3 FDA inspections on record, 2 Form 483s, last inspected September 24, 2026. Publicly traded as NASDAQ: ABEO.
Company Profile
This profile covers Abeona Therapeutics, Inc. based in Cleveland, Ohio, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 2
- Form 483s
- 2
- Warning letters
- 0
First inspected January 24, 2024. Last inspected September 24, 2026.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 24, 2026 | Not classified | Biologics | 1337492 |
| March 1, 2024 | Not classified | Biologics | 1264245 |
| January 24, 2024 | NAI | Biologics · Bioresearch Monitoring | 1231029 |
FDA documents
Form 483s (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Abeona Therapeutics, Inc.
Stock ticker
ABEO
Exchange
NASDAQ
Share price
$2.29
Market cap
$130.9M
Price as of
November 13, 2026
FEI Number
3008334517
Address
6555 Carnegie Ave, Cleveland, Ohio 44103, United States
Country
United States
ID: 9f67747d-0cf7-495e-a7d5-a4abfa60671a